Author

Tira Chaicha-Brom

Observed institution: Johnson & Johnson (United States)

OpenAlex ID: A5037918596

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

2023 · W Timothy Garvey, Juan P Frias, et al. · The Lancet · 921

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

2019 · Richard M. Bergenstal, Mark Peyrot, et al. · Diabetes Technology & Therapeutics · 40

DPP-IV Inhibitor-Associated Arthralgias

2013 · Tira Chaicha-Brom, Tahira Yasmeen · Endocrine Practice · 21

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Rodica Pop-Busui, Søren Rasmussen, et al. · JAMA Internal Medicine · 18

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial

2025 · Stephen J. Nicholls, Donna H. Ryan, et al. · JAMA Cardiology · 8

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Sharon L. Mulvagh, Silvio E. Inzucchi, et al. · JAMA Cardiology · 6

DPP-IV Inhibitor Associated Arthralgias

2012 · Tira Chaicha-Brom · Endocrine Practice · 6

Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial

2026 · John W. Ostrominski, Jorge Plutzky, et al. · JAMA Cardiology · 2

First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Nikolaus Marx, John E. Deanfield, et al. · JAMA Cardiology

Works count: 9

Citation count: 1,022

H-index: 6

I10-index: 4